Status:
UNKNOWN
MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients
Lead Sponsor:
People's Friendship University of Russia
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18-90 years
Brief Summary
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the third leading cause of cancer that related death in the worldwide. Although, current most of doctors and laboratorians...
Detailed Description
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the third leading cause of cancer that related death in the worldwide. According the burden of cancer in economically deve...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of HCC patients through history taking and physical Examination, AFP and ultrasonography (\> 5cm in size).
- Chronic liver disease patients with history of liver disease rather than HCC such as cirrhosis, chronic viral hepatitis, non-alcoholic liver disease (NALD).
- Healthy volunteers with no history of liver problems.
- Informed consent from all participants before enrollment in the study.
Exclusion
- HCC less than 5 cm in size during ultrasound examinations
- Extrahepatic disease, other primary tumour
- Inability to provide informed consent or who refused to draw off blood.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT03227510
Start Date
November 1 2017
End Date
September 1 2019
Last Update
July 25 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.